These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
188 related items for PubMed ID: 26575311
1. Impact of anaemia on long-term outcomes in patients treated with first- and second-generation drug-eluting stents; Katowice-Zabrze Registry. Wańha W, Kawecki D, Roleder T, Pluta A, Marcinkiewicz K, Dola J, Morawiec B, Krzych Ł, Pawłowski T, Smolka G, Ochała A, Nowalany-Kozielska E, Tendera M, Wojakowski W. Kardiol Pol; 2016; 74(6):561-9. PubMed ID: 26575311 [Abstract] [Full Text] [Related]
2. Gender differences and bleeding complications after PCI on first and second generation DES. Wanha W, Kawecki D, Roleder T, Pluta A, Marcinkiewicz K, Morawiec B, Kret M, Pawlowski T, Smolka G, Ochala A, Wojakowski W. Scand Cardiovasc J; 2017 Feb; 51(1):53-60. PubMed ID: 27471987 [Abstract] [Full Text] [Related]
3. First- Versus Second-Generation Drug-Eluting Stents in Acute Coronary Syndromes (Katowice-Zabrze Registry). Kawecki D, Morawiec B, Dola J, Wanha W, Smolka G, Pluta A, Marcinkiewicz K, Ochała A, Nowalany-Kozielska E, Wojakowski W. Arq Bras Cardiol; 2016 May; 106(5):373-81. PubMed ID: 27058257 [Abstract] [Full Text] [Related]
4. Second-generation drug-eluting stents in the elderly patients with acute coronary syndrome: the in-hospital and 12-month follow-up of the all-comer registry. Wańha W, Kawecki D, Roleder T, Morawiec B, Gładysz S, Kowalówka A, Jadczyk T, Adamus B, Pawłowski T, Smolka G, Kaźmierski M, Ochała A, Nowalany-Kozielska E, Wojakowski W. Aging Clin Exp Res; 2017 Oct; 29(5):885-893. PubMed ID: 27832467 [Abstract] [Full Text] [Related]
5. Drug-eluting versus bare-metal stents in large coronary arteries of patients with ST-segment elevation myocardial infarction: findings from the ICAS registry. Abe D, Sato A, Hoshi T, Maruta S, Misaki M, Kakefuda Y, Watabe H, Hiraya D, Sakai S, Kawabe M, Takeyasu N, Aonuma K. J Cardiol; 2014 Nov; 64(5):377-83. PubMed ID: 24685689 [Abstract] [Full Text] [Related]
6. Long-Term Percutaneous Coronary Intervention Outcomes of Patients with Chronic Kidney Disease in the Era of Second-Generation Drug-Eluting Stents. Wańha W, Kawecki D, Roleder T, Pluta A, Marcinkiewicz K, Morawiec B, Dola J, Gładysz S, Pawłowski T, Smolka G, Ochała A, Nowalany-Kozielska E, Wojakowski W. Cardiorenal Med; 2017 Feb; 7(2):85-95. PubMed ID: 28611782 [Abstract] [Full Text] [Related]
7. Comparison of First- and Second-Generation Drug-Eluting Stents in an All-Comer Population of Patients with Diabetes Mellitus (from Katowice-Zabrze Registry). Kawecki D, Morawiec B, Dola J, Wańha W, Smolka G, Pluta A, Marcinkiewicz K, Ochała A, Nowalany-Kozielska E, Wojakowski W. Med Sci Monit; 2015 Oct 27; 21():3261-9. PubMed ID: 26506478 [Abstract] [Full Text] [Related]
8. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial. Head SJ, Davierwala PM, Serruys PW, Redwood SR, Colombo A, Mack MJ, Morice MC, Holmes DR, Feldman TE, Ståhle E, Underwood P, Dawkins KD, Kappetein AP, Mohr FW. Eur Heart J; 2014 Oct 21; 35(40):2821-30. PubMed ID: 24849105 [Abstract] [Full Text] [Related]
9. Second vs. first-generation drug-eluting stents in complex lesions subsets: 3 years' follow-up of ERACI IV study. Rodriguez AE, Santaera O, Larribau M, Sarmiento R, Haiek C, Del Pozo JF, Pavlovsky H, Rodriguez-Granillo AM, ERACI IV Investigators. Minerva Cardioangiol; 2017 Feb 21; 65(1):81-90. PubMed ID: 27784884 [Abstract] [Full Text] [Related]
10. Five-year outcomes of surgical or percutaneous myocardial revascularization in diabetic patients. Contini GA, Nicolini F, Fortuna D, Pacini D, Gabbieri D, Vignali L, Valgimigli M, Manari A, Zussa C, Guastaroba P, De Palma R, Grilli R, Gherli T. Int J Cardiol; 2013 Sep 30; 168(2):1028-33. PubMed ID: 23164591 [Abstract] [Full Text] [Related]
16. Second versus first generation DES in multiple vessel disease and unprotected left main stenosis: insights from ERACI IV Study. Rodriguez AE. Minerva Cardioangiol; 2015 Aug 30; 63(4):317-27. PubMed ID: 25780954 [Abstract] [Full Text] [Related]
17. Drug-eluting stent for left main coronary artery disease. The DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. Chieffo A, Meliga E, Latib A, Park SJ, Onuma Y, Capranzano P, Valgimigli M, Jegere S, Makkar RR, Palacios IF, Kim YH, Buszman PE, Chakravarty T, Sheiban I, Mehran R, Naber C, Margey R, Agnihotri A, Marra S, Capodanno D, Leon MB, Moses JW, Fajadet J, Lefevre T, Morice MC, Erglis A, Tamburino C, Alfieri O, Serruys PW, Colombo A. JACC Cardiovasc Interv; 2012 Jul 30; 5(7):718-27. PubMed ID: 22814776 [Abstract] [Full Text] [Related]